Clinical medicine topic list of research papers
-
Single photon emission tomography as a predictor of outcome in vegetative state of head injury2012 / KurtA Jellinger
-
Efficacy of pneumatic dilatation as a definitive therapeutic modality for classic achalasia
Abstract Objective To evaluate pneumatic dilatation (PD) for cases of cardiac achalasia as a first-line therapy. Patients and methods The study included 35...
2013 / Ahmed Khafagy, Ibrahim Abdelnaby -
Use of anti-epileptic drugs in a tertiary care hospital of Eastern India with emphasis on epilepsy due to neurocysticercosis2012 / Amrita Sil, NilayK Das, Goutameswar Mazumdar, SantanuK Tripathi, Kamalesh Das, et al.
-
Systemic Treatment of Vitreous Inflammation2012 / John B. Christoforidis, Susie Chang, Angela Jiang, Jillian Wang, Colleen M. Cebulla
-
Entropy Best Paper Award 20132013 / Kevin Knuth
-
J wave syndromes as a cause of sudden arrhythmic death2013 / Charles Antzelevitch
-
Adopted guidelines of care for the topical management of psoriasis from American and German guidelines
Abstract Psoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. There is a genetic predisposition to psoriasis and has tendency to wax...
2011 / Ali A. Al Raddadi, Mohammad I. Fatani, Yasir H. Shaikh, Diamant Thaci, Abdullah A. Al Reshaid, et al. -
The Prognostic Significance of CD44V6, CDH11, and β -Catenin Expression in Patients with Osteosarcoma2013 / Zhouming Deng, Guangfeng Niu, Lin Cai, Renxiong Wei, Xiaolei Zhao
-
Extrauterine adenomyoma of the liver with a focally cellular smooth muscle component occurring in a patient with a history of myomectomy: case report and review of the literature2013 / Wu Huanwen, Zhang Hui, Xue Xiaowei, Lu Zhaohui
-
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy2011 / Andreas Pircher, Wolfgang Hilbe, Isabel Heidegger, Joachim Drevs, André Tichelli, et al.
-
Allogeneic transplantation for adult acute lymphoblastic leukemia: Intention to treat analysis of the EORTC ALL-4 phase III trial2006 / B. Labar, S. Suciu, P. Muus, R. Willemze, J.-P. Marie, et al.
-
Unrelated umbilical cord blood transplantation for familial erythrophagocytic lymphohistiocytosis2004 / B.L. Archambault, T.A. Driscoll, L.A. Stafford, P. Szabolcs, J. Kurtzberg, et al.
-
Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation
Abstract Increasing the upper age limit for recipients of hematopoietic stem cell transplantation (HCT) naturally has also increased the age of the corresponding related donor population. Because aging is a risk factor for malignancies, the risk of...
2006 / Olga Sala-Torra, Colleen Hanna, Michael R. Loken, Mary E.D. Flowers, Michael Maris, et al. -
Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol
Abstract We report the results of reduced-intensity conditioning allogeneic stem cell transplantation (allo-RIC) in patients with advanced Hodgkin lymphoma (HL). Forty patients with relapsed or refractory HL were homogeneously treated with an RIC...
2006 / Iván Alvarez, Anna Sureda, Maria D. Caballero, Alvaro Urbano-Ispizua, Josep M. Ribera, et al. -
Results of Unrelated Cord Blood Transplant in Fanconi Anemia Patients: Risk Factor Analysis for Engraftment and Survival
Abstract We retrospectively analyzed results of unrelated cord blood transplantation (UCBT) in 93 Fanconi anemia (FA) patients. Median age at transplantation was 8.6 years (1-45). The units transplanted were HLA-A, -B, or -DRB1 identical in 12...
2007 / Eliane Gluckman, Vanderson Rocha, Irina Ionescu, Marc Bierings, Richard E. Harris, et al. -
Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Abstract Autologous stem cell transplantation (ASCT) is the standard of care for patients with multiple myeloma (MM) younger than 70 years. However, despite this aggressive therapy most patients will still die of progressive disease. Recent reports...
2007 / Devendra K. Hiwase, Smita Hiwase, Michael Bailey, Geraldine Bollard, Anthony P. Schwarer -
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study
Abstract This study was conducted to define a new maximum tolerated dose and the dose-limiting toxicity (DLT) of melphalan and autologous hematopoietic stem cell transplantation (AHSCT) when used with the cytoprotective agent amifostine. Fifty-eight ...
2004 / G.L Phillips, B Meisenberg, D.E Reece, V.R Adams, A Badros, et al. -
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care2013 / Amikar Sehdev, Daniel VT Catenacci
-
Application of Dual Mask for Postoperative Respiratory Support in Obstructive Sleep Apnea Patient2013 / Jahan Porhomayon, Gino Zadeii, Nader D. Nader, George R. Bancroft, Alireza Yarahamadi
-
Diverging P waves after convergent procedures: What do they mean?2016 / Gopi Dandamudi